Protein detail

SPTN2

Spectrin beta chain, non-erythrocytic 2 (Beta-III spectrin) (Spinocerebellar ataxia 5 protein)

Entry name
SPTN2
UniProt ID
EVMP confidence score
0.28
Supporting publications (n)
1
Transmembrane count
Protein classification
Disease related genesHuman disease related genesPlasma proteinsPredicted intracellular proteins
Basic Information
Protein Names
Spectrin beta chain, non-erythrocytic 2 (Beta-III spectrin) (Spinocerebellar ataxia 5 protein)
Protein Class (4)
Disease related genesHuman disease related genesPlasma proteinsPredicted intracellular proteins
Protein Function (3)
  • Human disease related genes:Nervous system diseases:Neurodegenerative diseases
  • Disease related genes
  • Predicted intracellular proteins
Entrez Gene Symbol
Gene Synonym
SCA5
Gene Description
Spectrin beta, non-erythrocytic 2
Chromosome
11
Position
66682497-66744670
Supporting publications (n)
1
EVMP confidence score
0.28
Fluorescence & Localization
Tissue Specificskeletal muscleCell SpecificAdrenal cortex cellsSingle-Nuclei Brain Specificendothelial cell
Function & Pathway
Relations & Evidence21

Enzyme-Mediated Modification (1)

1 record.

Substrate Gene SymbolEnzyme Gene SymbolEnzyme UniProt IDResidue TypeResidue OffsetModificationDatabaseReferences
SPTBN2EGFP01133S2,171phosphorylationBEL-Large-Corpus_ProtMapperProtMapperProtMapper:17081983

Ligand-Receptor Signaling (9)

9 records.

CategoryParentDatabaseTransmitterReceiverSecretedPlasma Membrane (Transmembrane)Plasma Membrane (Peripheral)
ecmecmGO_IntercellYes
ecmecmOmniPathYes
extracellularextracellularOmniPath
intracellularintracellularComPPI
intracellularintracellularGO_Intercell
intracellularintracellularUniProt_location
intracellularintracellularOmniPath
ligandligandCellTalkDBYes
ligandligandOmniPathYes

Protein Complex Composition (10)

10 records.

Component NameComponent Gene SymbolsComponent UniProt IDStoichiometryDatabaseDatabase IDsReferences
Non-erythrocytic spectrinSPTAN1SPTBN2O15020Q138130:0SIGNORSIGNOR:SIGNOR-C385
LSM1LSM2LSM3LSM4LSM5SPTBN2O15020O15116P62310Q9Y333Q9Y4Y9Q9Y4Z00:0:0:0:0:0hu.MAP
LSM4LSM5LSM8SLU7SPTBSPTBN2O15020O95391O95777P11277Q9Y4Y9Q9Y4Z00:0:0:0:0:0hu.MAP
CRELD2LSM4LSM8MAGOHSLU7SPTBN2O15020O95391O95777P61326Q6UXH1Q9Y4Z00:0:0:0:0:0hu.MAP
KDM5CPBKSPTBN2THTPAUBA5USP5ZFP91O15020P41229P45974Q96JP5Q96KB5Q9BU02Q9GZZ90:0:0:0:0:0:0Havugimana2012Havugimana2012:C_533
LSM7RAD23ASPTBN2O15020P54725Q9UK450:0:0hu.MAP
ACTBSPTBN2O15020P607096:6PDBPDB:6anu
MAGOHSPTBN2O15020P613260:0hu.MAP
SPTAN1SPTBN1SPTBN2O15020Q01082Q138130:0:0hu.MAP2
SPTBN2TCEA2O15020Q155600:0hu.MAP2

Isolation & Detection Technology (1)

1 record.

EV Isolation MethodDetection MethodNumber of ReferencesReferences
Differential UltracentrifugationSize Exclusion ChromatographyMass spectrometry130550287
Sequence, Structure & Domains

Sequences

Length
2,390
Mass
271,325
Sequence
MSSTLSPTDFDSLEIQGQYSDINNRWDLPDSDWDNDSSSARLFERSRIKALADEREAVQKKTFTKWVNSHLARVTCRVGDLYSDLRDGRNLLRLLEVLSGEILPKPTKGRMRIHCLENVDKALQFLKEQKVHLENMGSHDIVDGNHRLTLGLVWTIILRFQIQDISVETEDNKEKKSAKDALLLWCQMKTAGYPNVNVHNFTTSWRDGLAFNAIVHKHRPDLLDFESLKKCNAHYNLQNAFNLAEKELGLTKLLDPEDVNVDQPDEKSIITYVATYYHYFSKMKALAVEGKRIGKVLDHAMEAERLVEKYESLASELLQWIEQTIVTLNDRQLANSLSGVQNQLQSFNSYRTVEKPPKFTEKGNLEVLLFTIQSKLRANNQKVYTPREGRLISDINKAWERLEKAEHERELALRTELIRQEKLEQLAARFDRKAAMRETWLSENQRLVSQDNFGLELAAVEAAVRKHEAIETDIVAYSGRVQAVDAVAAELAAERYHDIKRIAARQHNVARLWDFLRQMVAARRERLLLNLELQKVFQDLLYLMDWMEEMKGRLQSQDLGRHLAGVEDLLQLHELVEADIAVQAERVRAVSASALRFCNPGKEYRPCDPQLVSERVAKLEQSYEALCELAAARRARLEESRRLWRFLWEVGEAEAWVREQQHLLASADTGRDLTGALRLLNKHTALRGEMSGRLGPLKLTLEQGQQLVAEGHPGASQASARAAELQAQWERLEALAEERAQRLAQAASLYQFQADANDMEAWLVDALRLVSSPELGHDEFSTQALARQHRALEEEIRSHRPTLDALREQAAALPPTLSRTPEVQSRVPTLERHYEELQARAGERARALEAALALYTMLSEAGACGLWVEEKEQWLNGLALPERLEDLEVVQQRFETLEPEMNTLAAQITAVNDIAEQLLKANPPGKDRIVNTQEQLNHRWQQFRRLADGKKAALTSALSIQNYHLECTETQAWMREKTKVIESTQGLGNDLAGVLALQRKLAGTERDLEAIAARVGELTREANALAAGHPAQAVAINARLREVQTGWEDLRATMRRREESLGEARRLQDFLRSLDDFQAWLGRTQTAVASEEGPATLPEAEALLAQHAALRGEVERAQSEYSRLRALGEEVTRDQADPQCLFLRQRLEALGTGWEELGRMWESRQGRLAQAHGFQGFLRDARQAEGVLSSQEYVLSHTEMPGTLQAADAAIKKLEDFMSTMDANGERIHGLLEAGRQLVSEGNIHADKIREKADSIERRHKKNQDAAQQFLGRLRDNREQQHFLQDCHELKLWIDEKMLTAQDVSYDEARNLHTKWQKHQAFMAELAANKDWLDKVDKEGRELTLEKPELKALVSEKLRDLHRRWDELETTTQAKARSLFDANRAELFAQSCCALESWLESLQAQLHSDDYGKDLTSVNILLKKQQMLEWEMAVREKEVEAIQAQAKALAQEDQGAGEVERTSRAVEEKFRALCQPMRERCRRLQASREQHQFHRDVEDEILWVTERLPMASSMEHGKDLPSVQLLMKKNQTLQKEIQGHEPRIADLRERQRALGAAAAGPELAELQEMWKRLGHELELRGKRLEDALRAQQFYRDAAEAEAWMGEQELHMMGQEKAKDELSAQAEVKKHQVLEQALADYAQTIHQLAASSQDMIDHEHPESTRISIRQAQVDKLYAGLKELAGERRERLQEHLRLCQLRRELDDLEQWIQEREVVAASHELGQDYEHVTMLRDKFREFSRDTSTIGQERVDSANALANGLIAGGHAARATVAEWKDSLNEAWADLLELLDTRGQVLAAAYELQRFLHGARQALARVQHKQQQLPDGTGRDLNAAEALQRRHCAYEHDIQALSPQVQQVQDDGHRLQKAYAGDKAEEIGRHMQAVAEAWAQLQGSSAARRQLLLDTTDKFRFFKAVRELMLWMDEVNLQMDAQERPRDVSSADLVIKNQQGIKAEIEARADRFSSCIDMGKELLARSHYAAEEISEKLSQLQARRQETAEKWQEKMDWLQLVLEVLVFGRDAGMAEAWLCSQEPLVRSAELGCTVDEVESLIKRHEAFQKSAVAWEERFCALEKLTALEEREKERKRKREEEERRKQPPAPEPTASVPPGDLVGGQTASDTTWDGTQPRPPPSTQAPSVNGVCTDGEPSQPLLGQQRLEHSSFPEGPGPGSGDEANGPRGERQTRTRGPAPSAMPQSRSTESAHAATLPPRGPEPSAQEQMEGMLCRKQEMEAFGKKAANRSWQNVYCVLRRGSLGFYKDAKAASAGVPYHGEVPVSLARAQGSVAFDYRKRKHVFKLGLQDGKEYLFQAKDEAEMSSWLRVVNAAIATASSASGEPEEPVVPSTTRGMTRAMTMPPVSPVGAEGPVVLRSKDGREREREKRFSFFKKNK
Alternative Products
Event=Alternative splicing; Named isoforms=2; Name=1; IsoId=O15020-1; Sequence=Displayed; Name=2; IsoId=O15020-2; Sequence=VSP_000722
Alternative Sequence
2314..2390; AEMSSWLRVVNAAIATASSASGEPEEPVVPSTTRGMTRAMTMPPVSPVGAEGPVVLRSKDGREREREKRFSFFKKNK -> VSCPSCSSLSVPFQKLPAADSPSFPVLPLFPGLVLCGKTGCVRRPHQAALPV (in isoform 2)

3D Structural Models

Turn
220..222; 225..227; 256..258; 2265..2267
Helix
180..191; 209..218; 234..246; 266..282; 2261..2264; 2313..2328
Beta Strand
193..195; 205..208; 261..263; 283..285; 2221..2233; 2244..2251; 2254..2260; 2269..2272; 2282..2285; 2293..2299; 2301..2303; 2305..2309
3D Structure
Electron microscopy (1); NMR spectroscopy (2)

Domain & Motif Annotations

Compositional Bias
2081..2096; Basic and acidic residues; 2116..2125; Polar residues; 2370..2383; Basic and acidic residues
Repeat
306..414; Spectrin 1; 427..527; Spectrin 2; 532..639; Spectrin 3; 642..744; Spectrin 4; 749..849; Spectrin 5; 855..954; Spectrin 6; 960..1063; Spectrin 7; 1066..1169; Spectrin 8; 1174..1262; Spectrin 9; 1279..1379; Spectrin 10; 1384..1485; Spectrin 11; 1489..1586; Spectrin 12; 1589..1692; Spectrin 13; 1696..1797; Spectrin 14; 1801..1904; Spectrin 15; 1910..2010; Spectrin 16; 2017..2076; Spectrin 17
Domain (FT)
57..161; Calponin-homology (CH) 1; 176..281; Calponin-homology (CH) 2; 2218..2328; PH
Region
2..278; Actin-binding; 2081..2222; Disordered; 2331..2390; Disordered
Protein Families
Spectrin family
Sequence Similarities
Belongs to the spectrin family.
Clinical Relevance
Disease Involvement (3)
Disease variantNeurodegenerationSpinocerebellar ataxia
Related Diseases
Supporting Publications1
PMIDTitleRelated sentences
27601599Comprehensive Proteomic Analysis of Human Milk-derived Extracellular Vesicles Unveils a Novel Functional Proteome Distinct from Other Milk Components.No related sentences available